Radiotherapy with iodine-131 in recurrent malignant struma ovarii

European Journal of Nuclear Medicine
W BrennerE Henze

Abstract

Malignant struma ovarii is a very rare disease and, therefore, there is neither common agreement on treatment regimens nor sufficient follow-up experience. We present a case of a 49-year-old woman with malignant struma ovarii of the follicular type, who received ablative radioiodine treatment after thyroidectomy and surgical removal of the primary tumour. During follow-up examinations an increasing thyroglobulin level was found, caused by a tumour relapse with suspected urinary bladder infiltration on CT and proven uptake of radioiodine on whole-body scanning with iodine-131. After administration of 6GBq 131I, complete tumour regression was achieved with no evidence of a new relapse during a 30-month follow-up period. Correspondingly, repeated thyroglobulin measurements were all negative. This case demonstrates the benefit of combined surgical and radioiodine treatment of malignant struma ovarii for both monitoring and therapy of relapse or metastases; thus, the same therapeutic regimen as is employed in primary differentiated thyroid carcinoma may be recommended.

References

Aug 1, 1992·Geburtshilfe und Frauenheilkunde·F WierraniW Grünberger
Jul 1, 1992·Clinical Nuclear Medicine·R D Thomas, V B Batty
Jan 1, 1990·Journal of Surgical Oncology·A ZakhemP Salem
Jan 15, 1983·Cancer·F J Pardo-Mindan, J J Vazquez
Aug 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A AyhanS Ruacan
Oct 1, 1993·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·K DevaneyF A Tavassoli

❮ Previous
Next ❯

Citations

Feb 1, 1997·European Journal of Nuclear Medicine·L MangoG Ronga
Oct 23, 2008·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·P PrasadI Soomro
Jan 27, 1998·Clinical Nuclear Medicine·I JojaY Hiraki
Oct 24, 2000·Clinical Nuclear Medicine·P J Grandet, M H Remi
May 23, 2006·Clinical Nuclear Medicine·I Ross McDougall
Aug 30, 2008·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Lawrence M RothAleksander Talerman
Mar 1, 2012·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·S JeanC S Chu
Jan 29, 2011·Fertility and Sterility·Bernhard KraemerRalf Rothmund
Jun 15, 1999·Gynecologic Oncology·R B DardikF J Montz
Sep 25, 2007·Gynecologic and Obstetric Investigation·Mehrangiz HatamiGary L Goldberg
Apr 22, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Ruthy Shaco-LevyStanley J Robboy
Mar 18, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Julie F McGillPeter Angelos
May 9, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jessica E GosnellQuan-Yang Duh
Aug 14, 2012·Journal of Medical Imaging and Radiation Oncology·Raj K ShrimaliNick S Reed
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Sherry K SussmanAlan Heimann
Nov 5, 2019·Archives of Gynecology and Obstetrics·Molly R SiegelBiftu M Mengesha
Jul 6, 2021·The Journal of Obstetrics and Gynaecology Research·Sevgi AyhanGunsu Kimyon Comert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.